Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review.

Saved in:
Bibliographic Details
Title: Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review.
Authors: Cabezón-Gutiérrez L; Department of Medical Oncology, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain.; Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain., Palka-Kotlowska M; Department of Medical Oncology, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain.; Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain., Custodio-Cabello S; Department of Medical Oncology, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain., Rosero-Rodriguez AC; Department of Medical Oncology, Hospital Universitario de Torrejón, Torrejón de Ardoz, Spain., Chacón-Ovejero B; Department of Pharmacy and Nutrition, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
Source: Frontiers in oncology [Front Oncol] 2026 Jul 02; Vol. 16, pp. 1830731. Date of Electronic Publication: 2026 Jul 02 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2026.1830731